Your session is about to expire
← Back to Search
Smoke-Free Policy Support for Smoking Cessation
Study Summary
This trial will test two ways to reduce exposure to secondhand smoke in residential buildings. One targets all building residents, while the other targets smokers specifically, with the goal of reducing smoking and exposure to secondhand smoke.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I'm sorry, but this is not a clinical trial exclusion criterion. Can you please provide me with the correct criterion so I can rewrite it for you?The building is only for elderly people.I am over 18, live in the building most of the year, and won't move for 2 years.I am either a smoker or a non-smoker living in an apartment.My building project involves mixed financing.The study location cannot be in a building where other research studies are currently taking place.I do not have severe physical or mental conditions that would limit my participation in the study.You only smoke marijuana or other non-tobacco products.I have smoked at least 5 days in the past month or quit smoking more than a year ago.You were part of previous discussions about the topic.You are living in a NYCHA building in Manhattan or the Bronx.
- Group 1: Compliance through resident endorsement
- Group 2: Compliance through reduction/cessation plus resident endorsement (combined)
- Group 3: Standard NYCHA approach (control)
- Group 4: Compliance through reduction (relocation and reduction of personal smoking) and cessation
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
How many study subjects are you working with in total?
"That is correct, the online information does show that the study is recruiting patients. The clinical trial was first advertised on February 3rd, and there have been recent updates on February 18th. A total of 512 patients are needed for the study, which is only enrolling at a single site."
What are the researchers ultimately hoping to achieve with this trial?
"The key metric that this trial is measuring is change in salivary cotinine levels, which will be reported at the start of the study, 3 months in, and 12 months after the study has concluded. Additionally, the trial will also measure the number of successful quit attempts, the number of smokers, and the number of hours of secondhand smoke exposure."
Who else is applying?
What state do they live in?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
What questions have other patients asked about this trial?
Share this study with friends
Copy Link
Messenger